Genetics, molecular mechanisms and management of long QT syndrome.

Cardiac arrhythmias cause more than 300,000 sudden deaths each year in the USA alone. Long QT syndrome (LQT) is a cardiac disorder that causes sudden death from ventricular tachyarrhythmias, specifically torsade de pointes. Four LQT genes have been identified: KVLQT1 (LQT1) on chromosome 11p15.5, HERG (LQT2) on chromosome 7q35-36, SCN5A (LQT3) on chromosome 3p21-24, and MinK (LQT5) on chromosome 21q22. SCN5A encodes the cardiac sodium channel, and LQT-causing mutations in SCN5A lead to the generation of a late phase of inactivation-resistant whole-cell inward currents. Mexiletine, a sodium channel blocker, is effective in shortening the QT interval corrected for heart rate (QTc) of patients with SCN5A mutations. HERG encodes the cardiac I(Kr) potassium channel. Mutations in HERG act by a dominant-negative mechanism or by a loss-of-function mechanism. Raising the serum potassium concentration can increase outward HERG potassium current and is effective in shortening the QTc of patients with HERG mutations. KVLQT1 is a cardiac potassium channel protein that interacts with another small potassium channel MinK to form the cardiac I(Ks) potassium channel. Like HERG mutations, mutations in KVLQT1 and MinK can act by a dominant-negative mechanism or a loss-of-function mechanism. An effective treatment for LQT patients with KVLQT1 or MinK mutations is expected to be developed based on the functional characterization of the I(Ks) potassium channel. Genetic testing is now available for some patients with LQT.

[1]  H. Bazett,et al.  AN ANALYSIS OF THE TIME‐RELATIONS OF ELECTROCARDIOGRAMS. , 1997 .

[2]  A. Jervell,et al.  Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval, and sudden death , 1957 .

[3]  S. A. Levine,et al.  Congenital deaf-mutism, prolonged QT interval, syncopal attacks and sudden death. , 1958, The New England journal of medicine.

[4]  Ward Oc.  A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. , 1964 .

[5]  P FROGGATT,et al.  Genetical aspects of the cardio‐auditory syndrome of Jervell and Lange‐Nielsen (congenital deafness and electrocardiographic abnormalities) , 1964, Annals of human genetics.

[6]  H. Westling,et al.  CONGENITAL CARDIAC ARRHYTHMIA. , 1964, Lancet.

[7]  P FROGGATT,et al.  CONGENITAL DEAFNESS ASSOCIATED WITH ELECTROCARDIOGRAPHIC ABNORMALITIES, FAINTING ATTACKS AND SUDDEN DEATH. A RECESSIVE SYNDROME. , 1964, The Quarterly journal of medicine.

[8]  J. Barlow,et al.  CONGENITAL CARDIAC ARRHYTHMIA , 1964 .

[9]  C. Romano.  CONGENITAL CARDIAC ARRHYTHMIA. , 1965, Lancet.

[10]  D. Mcnamara,et al.  Heritable Q‐T Prolongation Without Deafness , 1970, Circulation.

[11]  A. Malliani,et al.  The long Q-T syndrome. , 1975, American heart journal.

[12]  E. Aliot,et al.  Ventricular tachyarrhythmias in the long QT syndromes. , 1984, The Medical clinics of North America.

[13]  Kossmann Ce.  The long Q-T interval and syndromes. , 1987 .

[14]  D. Zipes.  Proarrhythmic effects of antiarrhythmic drugs. , 1987, The American journal of cardiology.

[15]  A. Moss,et al.  The Long QT Syndrome: Prospective Longitudinal Study of 328 Families , 1991, Circulation.

[16]  M. Leppert,et al.  Consistent linkage of the long-QT syndrome to the Harvey ras-1 locus on chromosome 11. , 1991, American journal of human genetics.

[17]  M. Leppert,et al.  Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. , 1991, Science.

[18]  M. Leppert,et al.  The spectrum of symptoms and QT intervals in carriers of the gene for the long-QT syndrome. , 1992, The New England journal of medicine.

[19]  R Horn,et al.  Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[20]  B. Kerem,et al.  Evidence of genetic heterogeneity in the long QT syndrome. , 1993, Science.

[21]  M. Leppert,et al.  Locus heterogeneity of autosomal dominant long QT syndrome. , 1993, The Journal of clinical investigation.

[22]  J. Warmke,et al.  A family of potassium channel genes related to eag in Drosophila and mammals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Moss,et al.  Two long QT syndrome loci map to chromosomes 3 and 7 with evidence for further heterogeneity , 1994, Nature Genetics.

[24]  P. Schwartz,et al.  Evidence of Genetic Heterogeneity in Romano‐Ward Long QT syndrome: Analysis of 23 Families , 1994, Circulation.

[25]  C Antzelevitch,et al.  Clinical relevance of cardiac arrhythmias generated by afterdepolarizations. Role of M cells in the generation of U waves, triggered activity and torsade de pointes. , 1994, Journal of the American College of Cardiology.

[26]  A. Moss,et al.  Polymorphism of the gene encoding a human minimal potassium ion channel (minK). , 1994, Gene.

[27]  K. Koh,et al.  Torsade de pointes induced by terfenadine in a patient with long QT syndrome. , 1994, Journal of electrocardiology.

[28]  W. Cates,et al.  Early treatment of HIV infection. , 1995, The New England journal of medicine.

[29]  Arthur J Moss,et al.  SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome , 1995, Cell.

[30]  S. Priori,et al.  Long QT syndrome patients with mutations of the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate. Implications for gene-specific therapy. , 1995, Circulation.

[31]  G. Robertson,et al.  HERG, a human inward rectifier in the voltage-gated potassium channel family. , 1995, Science.

[32]  S. Priori,et al.  Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. , 1995, Human molecular genetics.

[33]  F. Charpentier,et al.  Mapping of a gene for long QT syndrome to chromosome 4q25-27. , 1995, American journal of human genetics.

[34]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[35]  A. George,et al.  Molecular mechanism for an inherited cardiac arrhythmia , 1995, Nature.

[36]  E. Green,et al.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[37]  M. Sanguinetti,et al.  Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel , 1996, Nature.

[38]  J. Seidman,et al.  Missense mutation in the pore region of HERG causes familial long QT syndrome. , 1996, Circulation.

[39]  A. Brown,et al.  HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. , 1996, Circulation.

[40]  P. Coumel,et al.  A mutation in HERG associated with notched T waves in long QT syndrome. , 1996, Journal of molecular and cellular cardiology.

[41]  P. Schwartz,et al.  Multiple mechanisms of Na+ channel--linked long-QT syndrome. , 1996, Circulation research.

[42]  R Lazzara,et al.  Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. , 1996, Circulation.

[43]  G. Landes,et al.  Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias , 1996, Nature Genetics.

[44]  F. Collins,et al.  KVLQT1 mutations in three families with familial or sporadic long QT syndrome. , 1996, Human molecular genetics.

[45]  J. Mason,et al.  Genetically defined therapy of inherited long-QT syndrome. Correction of abnormal repolarization by potassium. , 1996, Circulation.

[46]  M. Sanguinetti,et al.  Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Carlo Napolitano,et al.  Erratum: Long QT syndrome patients with mutations on the SCN5A and HERG genes have differential responses to Na+ channel blockade and to increases in heart rate: Implications for gene-specific therapy (Circulation (1995) 92 (3381-3386)) , 1996 .

[48]  F. Lang,et al.  Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole , 1996, FEBS letters.

[49]  Jacques Barhanin,et al.  KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current , 1996, Nature.

[50]  R. June,et al.  Torsades de pointes with terfenadine ingestion. , 1997, The American journal of emergency medicine.

[51]  S. Liu,et al.  Inhibition of L-type Ca2+ channel current in rat ventricular myocytes by terfenadine. , 1997, Circulation research.

[52]  M. Sanguinetti,et al.  Mutations in the hminK gene cause long QT syndrome and suppress lKs function , 1997, Nature Genetics.

[53]  S. Priori,et al.  The long QT syndrome. , 1997, Current problems in cardiology.

[54]  P. Coumel,et al.  A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome , 1997, Nature Genetics.

[55]  Glenn I. Fishman,et al.  A minK–HERG complex regulates the cardiac potassium current IKr , 1997, Nature.

[56]  Y. Yazaki,et al.  Four novel KVLQT1 and four novel HERG mutations in familial long-QT syndrome. , 1997, Circulation.

[57]  M. Blanar,et al.  Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome. , 1997, Circulation.

[58]  M. Keating,et al.  Molecular basis of the long-QT syndrome associated with deafness. , 1997, The New England journal of medicine.

[59]  G. Breithardt,et al.  KCNE1 mutations cause Jervell and Lange-Nielsen syndrome , 1997, Nature Genetics.